Generation Bio
Focus: Generation Bio is a Cambridge-based gene therapy biotech focused on oncology and genetic diseases. The company operates as a clinical-stage innovator in the specialized gene therapy space.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Generation Bio
AI assessmentNot HiringNo open roles listed right now. Follow Generation Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
Generic cephalosporin post-loss-of-exclusivity; likely acquired asset or legacy portfolio, not core to gene therapy strategy.
Products & Portfolio (1)
Help build intelligence for Generation Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.